UNSPSC 51371604: Tramadol hydrochloride

This classification denotes an analgesic agent with the molecular formula C16H25NO2.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 9N7R477WCK, chemically known as cyclohexanol, 2-((dimethylamino)methyl)-1-(m-methoxyphenyl)-, (+,-)-trans- but more generally known as tramadol hydrochloride, which bears US NIH Compound Identifier 5523. European Medicines Agency schedules Tramadol hydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB04927MIG.

Most nations, for tariff and trade purposes, schedule tramadol hydrochloride under HS 29225000 and SITC 51467. As of Q4 2014, TRAMADOL HYDROCHLORIDE remains US FDA's Preferred Term for this commodity. Tramadol hydrochloride bears US NLM identifiers UMLS ID C2350089 and NCI Concept Code C29508. SMILES: CN(C)C[C@H]1CCCC[C@@]1(C2CCCC(C2)OC)O.CL.

UNSPSC 51371604 Tramadol hydrochloride is a Commodity code that nominally describes a specific pharmaceutical product, but recent state and local solicitations show minimal activity directly aligned with this code. The single identifiable opportunity in the current procurement environment—Seminole County, Florida's IFB for naloxone and drug deactivation systems (IFB60459723LAS)—addresses opioid-reversal agents and harm-reduction equipment rather than tramadol itself, indicating a mismatch between the code's nominal scope and the work actually being solicited under it. State and local governments that do procure controlled-substance pharmaceuticals typically do so through health departments, correctional facilities, and public health agencies, but the recent record does not reflect active demand for tramadol specifically at the state or local level.

Seminole County's naloxone procurement, posted June 30, 2026, with a response deadline of July 26, 2023 (note the date inconsistency in the source), sought 1,900 units of naloxone and 800 safe drug deactivation systems annually through competitive bidding, with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida. The contract carries a two-year initial term with a one-year renewal option, requires E-Verify compliance and drug-free workplace certification, and includes potential FEMA funding with attendant federal environmental and compliance requirements. The code shows little recent activity beyond this single opportunity, and that opportunity addresses a different product category than the code's stated name. Firms pursuing tramadol or other controlled-substance procurements should monitor health-department and correctional-agency solicitations directly rather than rely on this code's recent posting pattern.